National Bank of Canada’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-954
| Closed | -$2.9K | – | 2765 |
|
|
2024
Q4 | $2.9K | Buy |
954
+22
| +2% | +$67 | ﹤0.01% | 2155 |
|
|
2024
Q3 | $4.84K | Sell |
932
-108
| -10% | -$561 | ﹤0.01% | 2032 |
|
|
2024
Q2 | $2.67K | Hold |
1,040
| – | – | ﹤0.01% | 2226 |
|
|
2024
Q1 | $3.44K | Hold |
1,040
| – | – | ﹤0.01% | 2186 |
|
|
2023
Q4 | $9.68K | Hold |
1,040
| – | – | ﹤0.01% | 1999 |
|
|
2023
Q3 | $11.6K | Hold |
1,040
| – | – | ﹤0.01% | 1940 |
|
|
2023
Q2 | $26.3K | Hold |
1,040
| – | – | ﹤0.01% | 1774 |
|
|
2023
Q1 | $33.5K | Hold |
1,040
| – | – | ﹤0.01% | 1701 |
|
|
2022
Q4 | $19.2K | Hold |
1,040
| – | – | ﹤0.01% | 1848 |
|
|
2022
Q3 | $28K | Hold |
1,040
| – | – | ﹤0.01% | 1751 |
|
|
2022
Q2 | $14K | Hold |
1,040
| – | – | ﹤0.01% | 1975 |
|
|
2022
Q1 | $20K | Hold |
1,040
| – | – | ﹤0.01% | 1957 |
|
|
2021
Q4 | $17K | Buy |
+1,040
| New | +$17K | ﹤0.01% | 1986 |
|